A German court on Wednesday ruled that Pfizer and its partner BioNTech violated a COVID-19 vaccine patent held by Moderna. In ...

As part of a global web of patent litigation over COVID-19 vaccines and mRNA technology, Pfizer and its partner BioNTech ...

A German court found Wednesday that American pharmaceutical giant Pfizer and German firm BioNTech violated a patent to make ...

Pfizer and BioNTech won a round in their legal battle with Moderna over COVID-19 vaccine patents on Wednesday, convincing a U ...

Patent Trial and Appeal Board (PTAB) docket entries indicate that the PTAB has invalidated all challenged claims of Moderna’s ...

Moderna's legal win boosts stock but highlights mRNA technology struggles. Discover why MRNA stock may not sustain long-term ...

MODERNA (MRNA, Financial) secured a major legal win in its COVID-19 vaccine patent dispute with Pfizer (PFE, Financial) and ...

Moderna (NASDAQ:MRNA) shares jumped 16% on Wednesday, March 5, following a favorable German court decision that determined ...

Moderna stock has surged more than 20% this week after regulatory filings showed several executives bought shares on the open ...

Lehigh County Courthouse staffer Adam Young sits with his face shield on as a juror would during a video shoot at the ...

The court said Pfizer and BioNTech would have to provide information on earnings derived from the use of the patent and that ...

DUESSELDORF, Germany, March 5 (Reuters) - A German court on Wednesday ruled that Pfizer (PFE.N), opens new tab and its partner BioNTech (22UAy.DE), opens new tab violated a COVID-19 vaccine patent ...